HR 3203 United States House · 118th Congress

Stop Chinese Fentanyl Act of 2023

HR 3203, the Stop Chinese Fentanyl Act of 2023, expands U.S. sanctions to target Chinese entities and government officials involved in fentanyl trafficking. It redefines "foreign opioid trafficker" to specifically include Chinese government bodies (like the National Narcotics Control Commission) and officials who fail to prevent fentanyl trafficking or cooperate with U.S. efforts. The bill also extends the statute of limitations for enforcement from 5 to 10 years under key laws and requires annual presidential reports to Congress on sanctions effectiveness. These changes directly affect Chinese government agencies and officials responsible for regulating or failing to combat fentanyl-related activities.
Bill status passed 3 of 5 stages cleared
Introduction
May 2023
Committee Review
Jul 2023
House Passage
Jul 2023
Senate Passage
President
Introduced May 11, 2023 Last action Jul 26, 2023
Maddy AI version diff · 1 comparison

What changed between versions

Introduced in House Engrossed in House · 7 edits · Jul 25, 2023
MODERATE
The Engrossed version of HR 3203 adds a non-binding Sense of Congress section urging China to cooperate on fentanyl precursors, narrows the definition of 'foreign opioid trafficker' for Chinese officials by requiring both regulatory responsibility and active aid/abetting (rather than either condition alone), limits IEEPA periodic evaluation requirements to drug trafficking emergencies specifically, and adds a new exception preventing sanctions from being applied to the importation of goods.
Scope change
The bill's scope was narrowed in two significant ways: (1) the definition of 'foreign opioid trafficker' for Chinese officials now requires both regulatory responsibility and active complicity rather than either alone, making designations harder; and (2) a new exception explicitly excludes importation of goods from sanctions authority. The IEEPA evaluation requirement was also narrowed to apply only to drug trafficking emergencies.
SCOPE

New Section 2 expresses the sense of Congress that China should work with the US on identifying unregulated precursor chemicals, require proper labeling of chemical shipments, implement know-your-customer procedures, and direct its agencies to crack down on precursor trafficking. This is non-binding but signals congressional expectations.

The definition of 'covered national emergency' for IEEPA periodic evaluation was changed from any emergency declared two or more years prior to the exercise of authority, to only emergencies regarding international drug trafficking declared within the preceding 5-year period. This narrows which emergencies trigger the annual reporting requirement.

The House Committee on Oversight and Accountability and Senate Committee on Homeland Security and Governmental Affairs were added as recipients of periodic IEEPA evaluations, expanding congressional oversight.

New Section 5 creates an exception stating that sanctions under this Act shall not include authority or a requirement to impose sanctions on the importation of goods. This carves out trade in physical goods from the sanctions regime, potentially limiting the bill's economic pressure on China.

DEFINITION

The definition of 'foreign opioid trafficker' for senior Chinese officials was narrowed. Previously, an official qualified if they had regulatory responsibilities over a trafficking entity OR failed to take credible steps against trafficking. Now both conditions must be met: the official must have regulatory responsibilities AND must aid and abet (including through intentional inaction) opioid trafficking. This makes it harder to designate Chinese officials.

REQUIREMENT

The President is now directed to specifically consider whether the heads of four named Chinese agencies (National Narcotics Control Commission, Ministry of Public Security, General Administration of Customs, and National Medical Products Administration) qualify as foreign opioid traffickers when making designations.

IEEPA regulation authority is now explicitly tied to 'a covered national emergency (as defined in section 203),' limiting the President's regulatory authority under this provision to drug trafficking emergencies rather than any national emergency.

Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
11
Key actions
2
Committee
3
Amendments
3
Jul 26, 2023
Committee
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
upper
Jul 25, 2023
Introduced
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3910-3911)
lower
Jul 25, 2023
Lower · Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3910-3911)
lower
Jul 25, 2023
Introduced
Mr. Barr moved to suspend the rules and pass the bill, as amended.
lower
May 16, 2023
Introduced
Ordered to be Reported (Amended) by Voice Vote.
lower
May 16, 2023
Lower · Passed
Committee Consideration and Mark-up Session Held.
lower
May 11, 2023
Committee
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Accountability, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 11, 2023
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors

Sponsors